Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Ra Capital Management, L.P. reported a 28.80% stake in Acrivon Therapeutics, Inc. (Schedule 13D/A)

Event Apr 22, 2026 · Filed Apr 23, 2026

Ra Capital Management, L.P. reported a 28.80% stake in Acrivon Therapeutics, Inc., 12,284,906 shares, with active intent on Apr 22, 2026. Filed Apr 23, 2026 (Schedule 13D/A).

Stake
28.80%
Shares
12,284,906
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
RA Capital Management, L.P.28.80%12,284,906
Peter Kolchinsky28.80%12,284,906
Rajeev Shah28.80%12,284,906
RA Capital Healthcare Fund, L.P.27.70%11,803,094

Source

View original at SEC

Related